Preliminary study on the diagnostic value of specific immune response indexes for bacterial negative pulmonary tuberculosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036909

Enrollment

Unknown

Registered

2020-08-25

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial negative pulmonary tuberculosis

Interventions

Gold Standard:Clinical outcome

Index test:serum&#32

interleukin&#32

15&#32

(IL-15)

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Suspected new sputum-negative tuberculosis patients, sputum-positive tuberculosis patients, patients with latent tuberculosis infection, lung cancer, pneumonia, and non-tuberculous mycobacteria; aged 18-50 years;

Exclusion criteria

Exclusion criteria: With immune system disease, severe liver and kidney disease, metabolic disease and other concurrent diseases; use of immunosuppressive drugs; history of active tuberculosis for more than one month;

Design outcomes

Primary

Measure	Time frame
IL-15;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactLiu Yidian

Shanghai Pulmonary Hospital

13816676933@139.com+86 13816676933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026